SCHEMBL18529293

SCHEMBL18529293

O=C(NCc1ccccc1)Nc1nc2ccc([N+](=O)[O-])cc2s1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
DYRK1A Q13627 2/20 0.63
SMN1; SMN2 Q16637 3/20 0.62
ALDH1A1 P00352 2/20 0.62
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
RXFP1 Q9HBX9 1/20 0.62
KMT2A Q03164 3/20 0.62
CXCR2 P25025 1/20 0.61
ACP1 P24666 2/20 0.60
MEN1 O00255 1/20 0.59
LMNA P02545 2/20 0.58
LCK P06239 1/20 0.58
POLB P06746 2/20 0.57
STAT1 P42224 1/20 0.57
MCL1 Q07820 1/20 0.57
CDK2 P24941 1/20 0.56
GSK3A P49840 1/20 0.56
GSK3B P49841 1/20 0.56
HIPK4 Q8NE63 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909104 0.84 CXCR2 (0.76) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1
SCHEMBL6068032 0.84 KMT2A (0.74) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1
SCHEMBL5001543 0.84 RIPK1 (0.63) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1
SCHEMBL17287743 0.83 MAPT (0.76) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1
SCHEMBL18541791 0.82 LCK (0.62) MAPTDYRK1ASMN1; SMN2NPC1RAB9A
SCHEMBL18541823 0.81 NPC1 (0.71) MAPTDYRK1ASMN1; SMN2NPC1RAB9A
SCHEMBL16732745 0.81 DYRK1A (0.78) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1
SCHEMBL2187627 0.81 NPC1 (0.80) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1
SCHEMBL6295875 0.79 CXCR2 (0.79) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1
SCHEMBL21568955 0.79 GSK3B (0.76) MAPTDYRK1ASMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017027984-A1 COMPOUNDS AND METHODS FOR TREATMENT OF CANCER BY INHIBITING ATG4B AND BLOCKING AUTOPHAGY SIMON FRASER UNIVERSITY (CA) 2017-02-23 WO disclosed